BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38760040)

  • 21. Perspectives of Screening-Eligible Women and Male Partners on Benefits of and Barriers to Treatment for Precancerous Lesions and Cervical Cancer in Kenya.
    Ragan KR; Buchanan Lunsford N; Lee Smith J; Saraiya M; Aketch M
    Oncologist; 2018 Jan; 23(1):35-43. PubMed ID: 28798272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A qualitative study to explore healthcare providers' perspectives on barriers and enablers to early detection of breast and cervical cancers among women attending primary healthcare clinics in Johannesburg, South Africa.
    Tshabalala G; Blanchard C; Mmoledi K; Malope D; O'Neil DS; Norris SA; Joffe M; Dietrich JJ
    PLOS Glob Public Health; 2023; 3(5):e0001826. PubMed ID: 37159437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the Barriers to Cervical Cancer Screening through the Lens of Implementers and Beneficiaries of the National Screening Program: A Multi-Contextual Study.
    Dsouza JP; Van Den Broucke S; Pattanshetty S; Dhoore W
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2209-2215. PubMed ID: 32856846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Côte d'Ivoire.
    Mensah K; Assoumou N; Duchesne V; Pourette D; DeBeaudrap P; Dumont A
    BMC Womens Health; 2020 Jul; 20(1):155. PubMed ID: 32723350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inequalities in cervical cancer screening in Eastern Europe: perspectives from Bulgaria and Romania.
    Todorova I; Baban A; Alexandrova-Karamanova A; Bradley J
    Int J Public Health; 2009; 54(4):222-32. PubMed ID: 19396397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge, facilitators and barriers to cervical cancer screening among women in Uganda: a qualitative study.
    Ndejjo R; Mukama T; Kiguli J; Musoke D
    BMJ Open; 2017 Jun; 7(6):e016282. PubMed ID: 28606908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of psychological barriers to cervical cancer screening among women in Kumasi, Ghana using a mixed methods approach.
    Williams M; Kuffour G; Ekuadzi E; Yeboah M; ElDuah M; Tuffour P
    Afr Health Sci; 2013 Dec; 13(4):1054-61. PubMed ID: 24940332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An empirical study of the 'underscreened' in organised cervical screening: experts focus on increasing opportunity as a way of reducing differences in screening rates.
    Williams JH; Carter SM
    BMC Med Ethics; 2016 Oct; 17(1):56. PubMed ID: 27716156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in providing breast and cervical cancer screening services to Vietnamese Canadian women: the healthcare providers' perspective.
    Donnelly TT
    Nurs Inq; 2008 Jun; 15(2):158-68. PubMed ID: 18476858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers and Facilitators to Cervical Cancer Screening in Western Kenya: a Qualitative Study.
    Adewumi K; Nishimura H; Oketch SY; Adsul P; Huchko M
    J Cancer Educ; 2022 Aug; 37(4):1122-1128. PubMed ID: 33411253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers to Cervical Cancer Screening and Treatment in the Dominican Republic: Perspectives of Focus Group Participants in the Santo Domingo Area.
    Liebermann EJ; VanDevanter N; Shirazian T; Frías Gúzman N; Niles M; Healton C; Ompad D
    J Transcult Nurs; 2020 Mar; 31(2):121-127. PubMed ID: 31046602
    [No Abstract]   [Full Text] [Related]  

  • 32. Understanding facilitators and barriers to follow-up after abnormal cervical cancer screening examination among women living in remote areas of Romania: a qualitative study protocol.
    Nyanchoka L; Damian A; Nygård M
    BMJ Open; 2022 Feb; 12(2):e053954. PubMed ID: 35197342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
    Oketch SY; Kwena Z; Choi Y; Adewumi K; Moghadassi M; Bukusi EA; Huchko MJ
    BMC Womens Health; 2019 Jun; 19(1):75. PubMed ID: 31196175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical Cancer Screening Experiences Among Chinese American Immigrant Women in the United States.
    Seo JY; Li J; Li K
    J Obstet Gynecol Neonatal Nurs; 2018 Jan; 47(1):52-63. PubMed ID: 29144960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the role of embarrassment in gynaecological screening: a qualitative study from the ASPIRE cervical cancer screening project in Uganda.
    Teng FF; Mitchell SM; Sekikubo M; Biryabarema C; Byamugisha JK; Steinberg M; Money DM; Ogilvie GS
    BMJ Open; 2014 Apr; 4(4):e004783. PubMed ID: 24727360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immigrant women's experiences and views on the prevention of cervical cancer: a qualitative study.
    Grandahl M; Tydén T; Gottvall M; Westerling R; Oscarsson M
    Health Expect; 2015 Jun; 18(3):344-54. PubMed ID: 23252449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia.
    Kivistik A; Lang K; Baili P; Anttila A; Veerus P
    BMC Womens Health; 2011 Sep; 11():43. PubMed ID: 21951661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers and facilitators to cervical cancer screening in high incidence populations: A synthesis of qualitative evidence.
    Driscoll SD
    Women Health; 2016; 56(4):448-67. PubMed ID: 26496628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women's experiences with opting out of cervical cancer screening and the role of the nurse in the women's decision-making process.
    Damsgaard S; Allergodt K; Handberg C
    J Clin Nurs; 2024 Jul; 33(7):2674-2687. PubMed ID: 38326939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge about cervical cancer, Pap test, and barriers to women's participation in screening in Belgrade, Serbia.
    Jovanovic V; Mitrovic Jovanovic A; Zivanovic A; Kocic S; Vasiljevic M; Krasic V
    Eur J Gynaecol Oncol; 2017; 38(1):69-75. PubMed ID: 29767868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.